Abstract
Patients and methods 62 patients affected by oligoarticular JIA that referred to our Departments in the period between December 2004 and June 2008, were included in the study. 34 cases (54%) had persistent oligoarthritis and the only affected joints were knee (45%) and ankle (9%). The remaining patients presented extended oligoarthritis and the involved joints, in addition to knee and ankle, were elbow (3%), wrist (3%), interphalangeal (6%). Triamcinolone hexacetonide and Methylprednisolone acetate were used. Patients were followed up for three years. MTX was started only if NSAIDs and IAC failed. Clinical pattern and serologic data, such as ESR and ANAs, were evaluated in order to correlate them with treatment response to predict the outcome of IAC procedure.
Highlights
Oligoarticular JIA encompasses two distinguished subtype: persistent oligoarthritis and extended oligoarthritis
Aim To evaluate the efficacy of the intra-articular corticosteroid therapy (IAC) in 62 patients affected by oligo-articular JIA
Patients and methods 62 patients affected by oligoarticular JIA that referred to our Departments in the period between December 2004 and June 2008, were included in the study. 34 cases (54%) had persistent oligoarthritis and the only affected joints were knee (45%) and ankle (9%)
Summary
Intra-articular corticosteroid therapy in oligoarticular juvenile arthritis: our clinical experience. C Trigilia1,2*, T Timpanaro, G Caff, G Belfiore, V Pavone, P Barone, R Garozzo. From 18th Pediatric Rheumatology European Society (PReS) Congress Bruges, Belgium. From 18th Pediatric Rheumatology European Society (PReS) Congress Bruges, Belgium. 14-18 September 2011
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
